http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108159065-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate | 2018-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108159065-B |
| titleOfInvention | Application of morroniside in promoting survival of ischemic overlong random skin flap |
| abstract | The invention relates to an effect of morroniside in promoting survival of ischemic random flap. An intraperitoneal injection mode is adopted in the process of promoting survival of the ischemic random flap, the using method is that the daily intraperitoneal injection dosage is 30mg/kg, and 5-7 days are a treatment course. A conclusion is drawn through a large number of animal experiments, the survival area ratio of the skin flap can be obviously improved by using the morroniside, and the survival of the ischemic random skin flap can be well promoted. |
| priorityDate | 2018-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 107.